MLH1 and Lynch syndrome: In Lynch syndrome with an hMLH1 or hMSH2 mutation, the frequencies of colorectal and endometrial cancers are 68% and 62%, respectively, and the lifetime risk of developing endometrial cancer is higher than that for colorectal cancer in women [5].